Customer Services

Generics: Global Industry Guide

Product Code DAT14235
Publication Date October 2009
Publisher Datamonitor
Product Type Report
Pages 226
Buy this product or for assistance call +44 20 7060 7474
PDF £985.00$1491 | €1099
PRINT £1,055.00$1597 | €1177
FAX Order above formats by FAX

Datamonitor's Generics: Global Industry Guide is an essential resource for top-level data and analysis covering the Generics industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

  • Contains an executive summary and data on value, volume and segmentation
  • Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies
  • Incorporates in-depth five forces competitive environment analysis and scorecards
  • Covers the Global, European and Asia-Pacific markets as well as individual chapters on 5 major markets (France, Germany, Japan, the UK and the US).
  • Includes a five-year forecast of the industry

Highlights

  • The global generics market grew by 3.1% in 2008 to reach a value of $191.8 billion.
  • In 2013, the global generics market is forecast to have a value of $292 billion, an increase of 52.2% since 2008.
  • Sales of ethical drugs proved the most lucrative for the global generics market in 2008, generating 80.9% of the market's overall revenue.
  • Americas leads the global generics market accounting for 59.7% of the market's revenue.

Why you should buy this report

  • Spot future trends and developments
  • Inform your business decisions
  • Add weight to presentations and marketing materials
  • Save time carrying out entry-level research

Market Definition

  • The generics market consists of all sales of generic drugs for human use at ex-manufacturer prices. Datamonitor defines a generic as an officially-approved copy of an original product whose patent has expired, marketed either as a brand or using the generic name.
  • This definition excludes multi-source copy products that make up much of markets such as India, Spain and Italy. Multi-source copies are drugs still under patent that are offered by manufacturers other than the patent holders.
  • Chapter 1 Introduction
    • 1.1 What Is This Report About?
    • 1.2 Who Is The Target Reader?
    • 1.3 How To Use This Report
    • 1.4 Definitions
  • Chapter 2 Global Generics
    • 2.1 Market Overview
    • 2.2 Market Value
    • 2.3 Market Segmentation I
    • 2.4 Market Segmentation Ii
    • 2.5 Five Forces Analysis
    • 2.6 Market Forecasts
  • Chapter 3 Generics In Asia-Pacific
    • 3.1 Market Overview
    • 3.2 Market Value
    • 3.3 Market Segmentation I
    • 3.4 Market Segmentation Ii
    • 3.5 Five Forces Analysis
    • 3.6 Market Forecasts
  • Chapter 4 Generics In Europe
    • 4.1 Market Overview
    • 4.2 Market Value
    • 4.3 Market Segmentation I
    • 4.4 Market Segmentation Ii
    • 4.5 Five Forces Analysis
    • 4.6 Market Forecasts
    • 4.7 Macroeconomic Indicators
  • Chapter 5 Generics In Belgium
    • 5.1 Market Overview
    • 5.2 Market Value
    • 5.3 Market Segmentation I
    • 5.4 Market Segmentation Ii
    • 5.5 Five Forces Analysis
    • 5.6 Market Forecasts
    • 5.7 Macroeconomic Indicators
  • Chapter 6 Generics In Canada
    • 6.1 Market Overview
    • 6.2 Market Value
    • 6.3 Market Segmentation I
    • 6.4 Market Segmentation Ii
    • 6.5 Five Forces Analysis
    • 6.6 Market Forecasts
    • 6.7 Macroeconomic Indicators
  • Chapter 7 Generics In China
    • 7.1 Market Overview
    • 7.2 Market Value
    • 7.3 Market Segmentation I
    • 7.4 Market Segmentation Ii
    • 7.5 Five Forces Analysis
    • 7.6 Market Forecasts
    • 7.7 Macroeconomic Indicators
  • Chapter 8 Generics In France
    • 8.1 Market Overview
    • 8.2 Market Value
    • 8.3 Market Segmentation I
    • 8.4 Market Segmentation Ii
    • 8.5 Five Forces Analysis
    • 8.6 Market Forecasts
    • 8.7 Macroeconomic Indicators
  • Chapter 9 Generics In Germany
    • 9.1 Market Overview
    • 9.2 Market Value
    • 9.3 Market Segmentation I
    • 9.4 Market Segmentation Ii
    • 9.5 Five Forces Analysis
    • 9.6 Market Forecasts
    • 9.7 Macroeconomic Indicators
  • Chapter 10 Generics In Italy
    • 10.1 Market Overview
    • 10.2 Market Value
    • 10.3 Market Segmentation I
    • 10.4 Market Segmentation Ii
    • 10.5 Five Forces Analysis
    • 10.6 Market Forecasts
    • 10.7 Macroeconomic Indicators
  • Chapter 11 Generics In Japan
    • 11.1 Market Overview
    • 11.2 Market Value
    • 11.3 Market Segmentation I
    • 11.4 Market Segmentation Ii
    • 11.5 Five Forces Analysis
    • 11.6 Market Forecasts
    • 11.7 Macroeconomic Indicators
  • Chapter 12 Generics In The Netherlands
    • 12.1 Market Overview
    • 12.2 Market Value
    • 12.3 Market Segmentation I
    • 12.4 Market Segmentation Ii
    • 12.5 Five Forces Analysis
    • 12.6 Market Forecasts
    • 12.7 Macroeconomic Indicators
  • Chapter 13 Generics In Spain
    • 13.1 Market Overview
    • 13.2 Market Value
    • 13.3 Market Segmentation I
    • 13.4 Market Segmentation Ii
    • 13.5 Five Forces Analysis
    • 13.6 Market Forecasts
    • 13.7 Macroeconomic Indicators
  • Chapter 14 Generics In The United Kingdom
    • 14.1 Market Overview
    • 14.2 Market Value
    • 14.3 Market Segmentation I
    • 14.4 Market Segmentation Ii
    • 14.5 Five Forces Analysis
    • 14.6 Market Forecasts
    • 14.7 Macroeconomic Indicators
  • Chapter 15 Generics In The United States
    • 15.1 Market Overview
    • 15.2 Market Value
    • 15.3 Market Segmentation I
    • 15.4 Market Segmentation Ii
    • 15.5 Five Forces Analysis
    • 15.6 Market Forecasts
    • 15.7 Macroeconomic Indicators
  • Chapter 16 Company Profiles
    • 16.1 Leading Companies
  • Chapter 17 Appendix
    • 17.1 Data Research Methodology
  • List Of Tables
    • Table 1: Global Generics Market Value: $ Billion, 2004-2008
    • Table 2: Global Generics Market Segmentation I: % Share, By Value, 2008
    • Table 3: Global Generics Market Segmentation Ii: % Share, By Value, 2008
    • Table 4: Global Generics Market Value Forecast: $ Billion, 2008-2013
    • Table 5: Asia-Pacific Generics Market Value: $ Billion, 2004-2008
    • Table 6: Asia-Pacific Generics Market Segmentation I: % Share, By Value, 2008
    • Table 7: Asia-Pacific Generics Market Segmentation Ii: % Share, By Value, 2008
    • Table 8: Asia-Pacific Generics Market Value Forecast: $ Billion, 2008-2013
    • Table 9: Europe Generics Market Value: $ Billion, 2004-2008
    • Table 10: Europe Generics Market Segmentation I: % Share, By Value, 2008
    • Table 11: Europe Generics Market Segmentation Ii: % Share, By Value, 2008
    • Table 12: Europe Generics Market Value Forecast: $ Billion, 2008-2013
    • Table 13: Europe Exchange Rate, 2004-2008
    • Table 14: Belgium Generics Market Value: $ Million, 2004-2008
    • Table 15: Belgium Generics Market Segmentation I: % Share, By Value, 2008
    • Table 16: Belgium Generics Market Segmentation Ii: % Share, By Value, 2008
    • Table 17: Belgium Generics Market Value Forecast: $ Million, 2008-2013
    • Table 18: Belgium Size Of Population (Million) , 2004-2008
    • Table 19: Belgium Gdp (Constant 2000 Prices, $ Billion), 2004-2008
    • Table 20: Belgium Inflation, 2004-2008
    • Table 21: Belgium Exchange Rate, 2004-2008
    • Table 22: Canada Generics Market Value: $ Billion, 2004-2008
    • Table 23: Canada Generics Market Segmentation I: % Share, By Value, 2008
    • Table 24: Canada Generics Market Segmentation Ii: % Share, By Value, 2008
    • Table 25: Canada Generics Market Value Forecast: $ Billion, 2008-2013
    • Table 26: Canada Size Of Population (Million) , 2004-2008
    • Table 27: Canada Gdp (Constant 2000 Prices, $ Billion), 2004-2008
    • Table 28: Canada Inflation, 2004-2008
    • Table 29: Canada Exchange Rate, 2004-2008
    • Table 30: China Generics Market Value: $ Billion, 2004-2008
    • Table 31: China Generics Market Segmentation I: % Share, By Value, 2008
    • Table 32: China Generics Market Segmentation Ii: % Share, By Value, 2008
    • Table 33: China Generics Market Value Forecast: $ Billion, 2008-2013
    • Table 34: China Size Of Population (Million) , 2004-2008
    • Table 35: China Gdp (Constant 2000 Prices, $ Billion), 2004-2008
    • Table 36: China Inflation, 2004-2008
    • Table 37: China Exchange Rate, 2004-2008
    • Table 38: France Generics Market Value: $ Billion, 2004-2008
    • Table 39: France Generics Market Segmentation I: % Share, By Value, 2008
    • Table 40: France Generics Market Segmentation Ii: % Share, By Value, 2008
    • Table 41: France Generics Market Value Forecast: $ Billion, 2008-2013
    • Table 42: France Size Of Population (Million) , 2004-2008
    • Table 43: France Gdp (Constant 2000 Prices, $ Billion), 2004-2008
    • Table 44: France Inflation, 2004-2008
    • Table 45: France Exchange Rate, 2004-2008
    • Table 46: Germany Generics Market Value: $ Billion, 2004-2008
    • Table 47: Germany Generics Market Segmentation I: % Share, By Value, 2008
    • Table 48: Germany Generics Market Segmentation Ii: % Share, By Value, 2008
    • Table 49: Germany Generics Market Value Forecast: $ Billion, 2008-2013
    • Table 50: Germany Size Of Population (Million) , 2004-2008
    • Table 51: Germany Gdp (Constant 2000 Prices, $ Billion), 2004-2008
    • Table 52: Germany Inflation, 2004-2008
    • Table 53: Germany Exchange Rate, 2004-2008
    • Table 54: Italy Generics Market Value: $ Million, 2004-2008
    • Table 55: Italy Generics Market Segmentation I: % Share, By Value, 2008
    • Table 56: Italy Generics Market Segmentation Ii: % Share, By Value, 2008
    • Table 57: Italy Generics Market Value Forecast: $ Million, 2008-2013
    • Table 58: Italy Size Of Population (Million) , 2004-2008
    • Table 59: Italy Gdp (Constant 2000 Prices, $ Billion), 2004-2008
    • Table 60: Italy Inflation, 2004-2008
    • Table 61: Italy Exchange Rate, 2004-2008
    • Table 62: Japan Generics Market Value: $ Billion, 2004-2008
    • Table 63: Japan Generics Market Segmentation I: % Share, By Value, 2008
    • Table 64: Japan Generics Market Segmentation Ii: % Share, By Value, 2008
    • Table 65: Japan Generics Market Value Forecast: $ Billion, 2008-2013
    • Table 66: Japan Size Of Population (Million) , 2004-2008
    • Table 67: Japan Gdp (Constant 2000 Prices, $ Billion), 2004-2008
    • Table 68: Japan Inflation, 2004-2008
    • Table 69: Japan Exchange Rate, 2004-2008
    • Table 70: Netherlands Generics Market Value: $ Million, 2004-2008
    • Table 71: Netherlands Generics Market Segmentation I: % Share, By Value, 2008
    • Table 72: Netherlands Generics Market Segmentation Ii: % Share, By Value, 2008
    • Table 73: Netherlands Generics Market Value Forecast: $ Million, 2008-2013
    • Table 74: Netherlands Size Of Population (Million) , 2004-2008
    • Table 75: Netherlands Gdp (Constant 2000 Prices, $ Billion), 2004-2008
    • Table 76: Netherlands Inflation, 2004-2008
    • Table 77: Netherlands Exchange Rate, 2004-2008
    • Table 78: Spain Generics Market Value: $ Million, 2004-2008
    • Table 79: Spain Generics Market Segmentation I: % Share, By Value, 2008
    • Table 80: Spain Generics Market Segmentation Ii: % Share, By Value, 2008
    • Table 81: Spain Generics Market Value Forecast: $ Million, 2008-2013
    • Table 82: Spain Size Of Population (Million) , 2004-2008
    • Table 83: Spain Gdp (Constant 2000 Prices, $ Billion), 2004-2008
    • Table 84: Spain Inflation, 2004-2008
    • Table 85: Spain Exchange Rate, 2004-2008
    • Table 86: United Kingdom Generics Market Value: $ Billion, 2004-2008
    • Table 87: United Kingdom Generics Market Segmentation I: % Share, By Value, 2008
    • Table 88: United Kingdom Generics Market Segmentation Ii: % Share, By Value, 2008
    • Table 89: United Kingdom Generics Market Value Forecast: $ Billion, 2008-2013
    • Table 90: United Kingdom Size Of Population (Million) , 2004-2008
    • Table 91: United Kingdom Gdp (Constant 2000 Prices, $ Billion), 2004-2008
    • Table 92: United Kingdom Inflation, 2004-2008
    • Table 93: United Kingdom Exchange Rate, 2004-2008
    • Table 94: United States Generics Market Value: $ Billion, 2004-2008
    • Table 95: United States Generics Market Segmentation I: % Share, By Value, 2008
    • Table 96: United States Generics Market Segmentation Ii: % Share, By Value, 2008
    • Table 97: United States Generics Market Value Forecast: $ Billion, 2008-2013
    • Table 98: United States Size Of Population (Million) , 2004-2008
    • Table 99: United States Gdp (Constant 2000 Prices, $ Billion), 2004-2008
    • Table 100: United States Inflation, 2004-2008
    • Table 101: Key Facts: Teva Pharmaceutical Industries
    • Table 102: Key Financials: Teva Pharmaceutical Industries
    • Table 103: Key Facts: Sandoz Gmbh
    • Table 104: Key Facts: Mylan Laboratories Inc
    • Table 105: Key Financials: Mylan Laboratories Inc
  • List Of Figures
    • Figure 1: Global Generics Market Value: $ Billion, 2004-2008
    • Figure 2: Global Generics Market Segmentation I: % Share, By Value, 2008
    • Figure 3: Global Generics Market Segmentation Ii: % Share, By Value, 2008
    • Figure 4: Forces Driving Competition In The Global Generics Market, 2008
    • Figure 5: Drivers Of Buyer Power In The Global Generics Market, 2008
    • Figure 6: Drivers Of Supplier Power In The Global Generics Market, 2008
    • Figure 7: Factors Influencing The Likelihood Of New Entrants In The Global Generics Market, 2008
    • Figure 8: Factors Influencing The Threat Of Substitutes In The Global Generics Market, 2008
    • Figure 9: Drivers Of Degree Of Rivalry In The Global Generics Market, 2008
    • Figure 10: Global Generics Market Value Forecast: $ Billion, 2008-2013
    • Figure 11: Asia-Pacific Generics Market Value: $ Billion, 2004-2008
    • Figure 12: Asia-Pacific Generics Market Segmentation I: % Share, By Value, 2008
    • Figure 13: Asia-Pacific Generics Market Segmentation Ii: % Share, By Value, 2008
    • Figure 14: Forces Driving Competition In The Generics Market In Asia-Pacific, 2008
    • Figure 15: Drivers Of Buyer Power In The Generics Market In Asia-Pacific, 2008
    • Figure 16: Drivers Of Supplier Power In The Generics Market In Asia-Pacific, 2008
    • Figure 17: Factors Influencing The Likelihood Of New Entrants In The Generics Market In Asia-Pacific, 2008
    • Figure 18: Factors Influencing The Threat Of Substitutes In The Generics Market In Asia-Pacific, 2008
    • Figure 19: Drivers Of Degree Of Rivalry In The Generics Market In Asia-Pacific, 2008
    • Figure 20: Asia-Pacific Generics Market Value Forecast: $ Billion, 2008-2013
    • Figure 21: Europe Generics Market Value: $ Billion, 2004-2008
    • Figure 22: Europe Generics Market Segmentation I: % Share, By Value, 2008
    • Figure 23: Europe Generics Market Segmentation Ii: % Share, By Value, 2008
    • Figure 24: Forces Driving Competition In The Generics Market In Europe, 2008
    • Figure 25: Drivers Of Buyer Power In The Generics Market In Europe, 2008
    • Figure 26: Drivers Of Supplier Power In The Generics Market In Europe, 2008
    • Figure 27: Factors Influencing The Likelihood Of New Entrants In The Generics Market In Europe, 2008
    • Figure 28: Factors Influencing The Threat Of Substitutes In The Generics Market In Europe, 2008
    • Figure 29: Drivers Of Degree Of Rivalry In The Generics Market In Europe, 2008
    • Figure 30: Europe Generics Market Value Forecast: $ Billion, 2008-2013
    • Figure 31: Belgium Generics Market Value: $ Million, 2004-2008
    • Figure 32: Belgium Generics Market Segmentation I: % Share, By Value, 2008
    • Figure 33: Belgium Generics Market Segmentation Ii: % Share, By Value, 2008
    • Figure 34: Forces Driving Competition In The Generics Market In Belgium, 2008
    • Figure 35: Drivers Of Buyer Power In The Generics Market In Belgium, 2008
    • Figure 36: Drivers Of Supplier Power In The Generics Market In Belgium, 2008
    • Figure 37: Factors Influencing The Likelihood Of New Entrants In The Generics Market In Belgium, 2008
    • Figure 38: Factors Influencing The Threat Of Substitutes In The Generics Market In Belgium, 2008
    • Figure 39: Drivers Of Degree Of Rivalry In The Generics Market In Belgium, 2008
    • Figure 40: Belgium Generics Market Value Forecast: $ Million, 2008-2013
    • Figure 41: Canada Generics Market Value: $ Billion, 2004-2008
    • Figure 42: Canada Generics Market Segmentation I: % Share, By Value, 2008
    • Figure 43: Canada Generics Market Segmentation Ii: % Share, By Value, 2008
    • Figure 44: Forces Driving Competition In The Generics Market In Canada, 2008
    • Figure 45: Drivers Of Buyer Power In The Generics Market In Canada, 2008
    • Figure 46: Drivers Of Supplier Power In The Generics Market In Canada, 2008
    • Figure 47: Factors Influencing The Likelihood Of New Entrants In The Generics Market In Canada, 2008
    • Figure 48: Factors Influencing The Threat Of Substitutes In The Generics Market In Canada, 2008
    • Figure 49: Drivers Of Degree Of Rivalry In The Generics Market In Canada, 2008
    • Figure 50: Canada Generics Market Value Forecast: $ Billion, 2008-2013
    • Figure 51: China Generics Market Value: $ Billion, 2004-2008
    • Figure 52: China Generics Market Segmentation I: % Share, By Value, 2008
    • Figure 53: China Generics Market Segmentation Ii: % Share, By Value, 2008
    • Figure 54: Forces Driving Competition In The Generics Market In China, 2008
    • Figure 55: Drivers Of Buyer Power In The Generics Market In China, 2008
    • Figure 56: Drivers Of Supplier Power In The Generics Market In China, 2008
    • Figure 57: Factors Influencing The Likelihood Of New Entrants In The Generics Market In China, 2008
    • Figure 58: Factors Influencing The Threat Of Substitutes In The Generics Market In China, 2008
    • Figure 59: Drivers Of Degree Of Rivalry In The Generics Market In China, 2008
    • Figure 60: China Generics Market Value Forecast: $ Billion, 2008-2013
    • Figure 61: France Generics Market Value: $ Billion, 2004-2008
    • Figure 62: France Generics Market Segmentation I: % Share, By Value, 2008
    • Figure 63: France Generics Market Segmentation Ii: % Share, By Value, 2008
    • Figure 64: Forces Driving Competition In The Generics Market In France, 2008
    • Figure 65: Drivers Of Buyer Power In The Generics Market In France, 2008
    • Figure 66: Drivers Of Supplier Power In The Generics Market In France, 2008
    • Figure 67: Factors Influencing The Likelihood Of New Entrants In The Generics Market In France, 2008
    • Figure 68: Factors Influencing The Threat Of Substitutes In The Generics Market In France 2008
    • Figure 69: Drivers Of Degree Of Rivalry In The Generics Market In France, 2008
    • Figure 70: France Generics Market Value Forecast: $ Billion, 2008-2013
    • Figure 71: Germany Generics Market Value: $ Billion, 2004-2008
    • Figure 72: Germany Generics Market Segmentation I: % Share, By Value, 2008
    • Figure 73: Germany Generics Market Segmentation Ii: % Share, By Value, 2008
    • Figure 74: Forces Driving Competition In The Generics Market In Germany, 2008
    • Figure 75: Drivers Of Buyer Power In The Generics Market In Germany, 2008
    • Figure 76: Drivers Of Supplier Power In The Generics Market In Germany, 2008
    • Figure 77: Factors Influencing The Likelihood Of New Entrants In The Generics Market In Germany, 2008
    • Figure 78: Factors Influencing The Threat Of Substitutes In The Generics Market In Germany, 2008
    • Figure 79: Drivers Of Degree Of Rivalry In The Generics Market In Germany, 2008
    • Figure 80: Germany Generics Market Value Forecast: $ Billion, 2008-2013
    • Figure 81: Italy Generics Market Value: $ Million, 2004-2008
    • Figure 82: Italy Generics Market Segmentation I: % Share, By Value, 2008
    • Figure 83: Italy Generics Market Segmentation Ii: % Share, By Value, 2008
    • Figure 84: Forces Driving Competition In The Generics Market In Italy, 2008
    • Figure 85: Drivers Of Buyer Power In The Generics Market In Italy, 2008
    • Figure 86: Drivers Of Supplier Power In The Generics Market In Italy, 2008
    • Figure 87: Factors Influencing The Likelihood Of New Entrants In The Generics Market In Italy, 2008
    • Figure 88: Factors Influencing The Threat Of Substitutes In The Generics Market In Italy, 2008
    • Figure 89: Drivers Of Degree Of Rivalry In The Generics Market In Italy, 2008
    • Figure 90: Italy Generics Market Value Forecast: $ Million, 2008-2013
    • Figure 91: Japan Generics Market Value: $ Billion, 2004-2008
    • Figure 92: Japan Generics Market Segmentation I: % Share, By Value, 2008
    • Figure 93: Japan Generics Market Segmentation Ii: % Share, By Value, 2008
    • Figure 94: Forces Driving Competition In The Generics Market In Japan, 2008
    • Figure 95: Drivers Of Buyer Power In The Generics Market In Japan, 2008
    • Figure 96: Drivers Of Supplier Power In The Generics Market In Japan, 2008
    • Figure 97: Factors Influencing The Likelihood Of New Entrants In The Generics Market In Japan, 2008
    • Figure 98: Factors Influencing The Threat Of Substitutes In The Generics Market In Japan, 2008
    • Figure 99: Drivers Of Degree Of Rivalry In The Generics Market In Japan, 2008
    • Figure 100: Japan Generics Market Value Forecast: $ Billion, 2008-2013
    • Figure 101: Netherlands Generics Market Value: $ Million, 2004-2008
    • Figure 102: Netherlands Generics Market Segmentation I: % Share, By Value, 2008
    • Figure 103: Netherlands Generics Market Segmentation Ii: % Share, By Value, 2008
    • Figure 104: Forces Driving Competition In The Generics Market In The Netherlands, 2008
    • Figure 105: Drivers Of Buyer Power In The Generics Market In The Netherlands, 2008
    • Figure 106: Drivers Of Supplier Power In The Generics Market In The Netherlands, 2008
    • Figure 107: Factors Influencing The Likelihood Of New Entrants In The Generics Market In The Netherlands, 2008
    • Figure 108: Factors Influencing The Threat Of Substitutes In The Generics Market In The Netherlands, 2008
    • Figure 109: Drivers Of Degree Of Rivalry In The Generics Market In The Netherlands, 2008
    • Figure 110: Netherlands Generics Market Value Forecast: $ Million, 2008-2013
    • Figure 111: Spain Generics Market Value: $ Million, 2004-2008
    • Figure 112: Spain Generics Market Segmentation I: % Share, By Value, 2008
    • Figure 113: Spain Generics Market Segmentation Ii: % Share, By Value, 2008
    • Figure 114: Forces Driving Competition In The Generics Market In Spain, 2008
    • Figure 115: Drivers Of Buyer Power In The Generics Market In Spain, 2008
    • Figure 116: Drivers Of Supplier Power In The Generics Market In Spain, 2008
    • Figure 117: Factors Influencing The Likelihood Of New Entrants In The Generics Market In Spain, 2008
    • Figure 118: Factors Influencing The Threat Of Substitutes In The Generics Market In Spain, 2008
    • Figure 119: Drivers Of Degree Of Rivalry In The Generics Market In Spain, 2008
    • Figure 120: Spain Generics Market Value Forecast: $ Million, 2008-2013
    • Figure 121: United Kingdom Generics Market Value: $ Billion, 2004-2008
    • Figure 122: United Kingdom Generics Market Segmentation I: % Share, By Value, 2008
    • Figure 123: United Kingdom Generics Market Segmentation Ii: % Share, By Value, 2008
    • Figure 124: Forces Driving Competition In The Generics Market In The United Kingdom, 2008
    • Figure 125: Drivers Of Buyer Power In The Generics Market In The United Kingdom, 2008
    • Figure 126: Drivers Of Supplier Power In The Generics Market In The United Kingdom, 2008
    • Figure 127: Factors Influencing The Likelihood Of New Entrants In The Generics Market In The United Kingdom, 2008
    • Figure 128: Factors Influencing The Threat Of Substitutes In The Generics Market In The United Kingdom, 2008
    • Figure 129: Drivers Of Degree Of Rivalry In The Generics Market In The United Kingdom, 2008
    • Figure 130: United Kingdom Generics Market Value Forecast: $ Billion, 2008-2013
    • Figure 131: United States Generics Market Value: $ Billion, 2004-2008
    • Figure 132: United States Generics Market Segmentation I: % Share, By Value, 2008
    • Figure 133: United States Generics Market Segmentation Ii: % Share, By Value, 2008
    • Figure 134: Forces Driving Competition In The Generics Market In The United States, 2008
    • Figure 135: Drivers Of Buyer Power In The Generics Market In The United States, 2008
    • Figure 136: Drivers Of Supplier Power In The Generics Market In The United States, 2008
    • Figure 137: Factors Influencing The Likelihood Of New Entrants In The Generics Market In The United States, 2008
    • Figure 138: Factors Influencing The Threat Of Substitutes In The Generics Market In The United States, 2008
    • Figure 139: Drivers Of Degree Of Rivalry In The Generics Market In The United States, 2008
    • Figure 140: United States Generics Market Value Forecast: $ Billion, 2008-2013
    • Figure 141: Revenues & Profitability: Teva Pharmaceutical Industries
    • Figure 142: Revenues & Profitability: Mylan Laboratories Inc
Back to top

Delivery Details

PDF:Delivered by email usually within 4 to 8 UK business hours.

PRINT/CD-ROM:Despatched within 1 to 2 working days.

Actions

© 2010 | Report Buyer is a trading name for Piribo Ltd. Registered in England and Wales No. 05051530 | VAT Reg No. GB 839 4556 85

comodo ev ssl site
Internet shopping is safe
SecurityMetrics for PCI Compliance, QSA, IDS, Penetration Testing, Forensics, and Vulnerability Assessment